Detalles de la búsqueda
1.
Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial.
Int J Gynecol Cancer
; 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658017
2.
Extracellular vesicles in anti-tumor immunity.
Semin Cancer Biol
; 86(Pt 1): 64-79, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34509614
3.
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.
Cell Commun Signal
; 18(1): 156, 2020 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32967672
4.
Y90-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers.
Gut
; 72(2): 406-407, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35508369
5.
Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures.
J Surg Oncol
; 113(6): 708-14, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27020965
6.
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27.
Clin Genitourin Cancer
; 22(3): 102078, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38631104
7.
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes.
Eur J Surg Oncol
; 50(4): 108018, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428106
8.
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
NPJ Breast Cancer
; 9(1): 27, 2023 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37069173
9.
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
Ther Adv Med Oncol
; 15: 17588359231204857, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38130467
10.
Low baseline neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict increased overall survival in locally recurrent rectal cancer despite R1 margins.
Dig Liver Dis
; 54(7): 864-870, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35093274
11.
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study).
JAMA Oncol
; 8(6): 910-913, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35420628
12.
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles.
J Invest Dermatol
; 142(11): 3030-3040.e5, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35643181
13.
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer.
Cancer Discov
; 12(1): 90-107, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789537
14.
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia.
Vaccines (Basel)
; 10(4)2022 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35455328
15.
Risk assessment of thromboembolic events in hospitalized cancer patients.
Sci Rep
; 11(1): 18200, 2021 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34521927
16.
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients.
Clin Transl Med
; 11(6): e434, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185403
17.
The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma Patients.
Cancers (Basel)
; 13(16)2021 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34439311
18.
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients.
J Immunother Cancer
; 9(2)2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33589521
19.
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Clin Cancer Res
; 27(12): 3443-3455, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785482
20.
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.
J Clin Invest
; 128(12): 5505-5516, 2018 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30260323